Old Web
English
Sign In
Acemap
>
authorDetail
>
Xiaofei Zhou
Xiaofei Zhou
Bristol-Myers Squibb
Medicine
Pharmacokinetics
Oral administration
Surgery
Dosing
3
Papers
26
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase I, dose-escalation study of the investigational drug TAK-733, an oral MEK inhibitor, in patients (pts) with advanced solid tumors.
2017
Journal of Clinical Oncology
Alex A. Adjei
Patricia LoRusso
Antoni Ribas
Jeffrey A. Sosman
Anna C. Pavlick
Grace K. Dy
Xiaofei Zhou
Esha Gangolli
Russell M Walker
Michelle Kneissl
Stephanie Faucette
Rachel Neuwirth
Viviana Bozon
Show All
Source
Cite
Save
Citations (6)
A phase 1 study of BMS-275183, a novel oral analogue of paclitaxel given on a daily schedule to patients with advanced malignancies.
2011
Investigational New Drugs
Elisabeth I. Heath
Patricia LoRusso
Suresh S. Ramalingam
Ahmad Awada
Merrill J. Egorin
Tatiana Besse-Hamer
Fatima Cardoso
Manuel Valdivieso
Teresa Has
Leila Alland
Xiaofei Zhou
Chandra P. Belani
Show All
Source
Cite
Save
Citations (15)
Effect of Food on the Pharmacokinetic Behavior of the Potent Oral Taxane BMS-275183
2008
Clinical Cancer Research
Linda E. Bröker
Manual Valdivieso
Mary Jo Pilat
Pamela DeLuca
Xiaofei Zhou
Susan M. Parker
Giuseppe Giaccone
Patricia LoRusso
Show All
Source
Cite
Save
Citations (5)
1